We’re working on improving the following processes to make human cryopreservation better and more efficient.
In most cases, either field washout (i.e. no on site perfusion of cryoprotective agent) or a neuro-focus CPA perfusion is used. This means that the patient is at a warmer temperature at the end of standby procedures, leading to more degradation before vitrification occurs at the long-term care facility.
Protocols and equipment targeted at whole-body field cryoprotection/perfusion allows for local cooldown to dry ice temperatures, enabling longer transport times without degradation and higher quality cryopreservations.
We’re working on improving the following processes to make human cryopreservation better and more efficient.
We’re working on improving the following processes to make human cryopreservation better and more efficient.